COVID-19 in Delhi: 399 fresh cases, 12 more deaths; positivity rate dips to 0.51%

The tally of active cases dropped to 3,468 from 3,683 the previous day, while the positivity rate was recorded at 0.51 percent.

PTI
January 10, 2021 / 05:21 PM IST

Delhi recorded 399 fresh COVID-19 cases on Sunday, even as the positivity rate dipped to 0.51 percent, authorities said. The case tally in the city has gone past 6.30 lakh and the death toll due to the viral disease has mounted to 10,678, they said.

This month, 585 coronavirus cases were reported on January 1, 494 on January 2, 424 on January 3, 384 on January 4, 442 on January 5, 654 on January 6, 486 on January 7, 444 on January 8 and 519 on Saturday.

The tally of active cases dropped to 3,468 from 3,683 the previous day, while the positivity rate was recorded at 0.51 percent.

Delhi Health Minister Satyendar Jain said the city has been witnessing less than 1,000 fresh cases per day for the last 15 days.

"The COVID-19 situation in Delhi has improved a lot and it is now under control," he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

On December 29 and 30 last year, the city had recorded 703 and 677 fresh coronavirus cases respectively. On December 31, 574 cases were reported.

The 399 new cases came out of the 77,600 tests conducted the previous day, including 45,116 RT-PCR tests and 32,484 rapid-antigen tests, according to the latest bulletin issued by the Delhi health department.

The bulletin said the total number of cases has climbed to 6,30,200 in the city, while the recovery rate is over 97 percent.

According to the bulletin, of the total number of 12,115 beds in COVID hospitals, 10,677 are vacant.

The number of tests done per million was over 4.9 lakh as on Saturday while the total number of tests conducted stood at over 93 lakh.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #Current Affairs #Delhi #India
first published: Jan 10, 2021 05:19 pm